How much revenue does Kali make?

Kali reported $94.55 million in revenue for fiscal year 2012, up 6.4% from $88.83 million in fiscal year 2011. In Q1 2013 revenue was $26.61 million.

What companies are similar to Kali?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Avidus Management Group (ASNHF), Yooma Wellness Inc. (LVVEF), Genex Pharmaceutical, Inc. (GENX), Priority Aviation, Inc. (PJET).

Kali, Inc. (KALY) Stock

About Kali, Inc.

Kali, Inc., doing business as Kali-Extracts, Inc., engages in the research and development of cannabis treatments for various illnesses, diseases, and chronic pain as a symptom of various diagnoses. It provides pharmaceuticals, cannabis extracts, and health and wellness products. The company was formerly known as VLOV Inc. and changed its name to Kali, Inc. in February 2016. Kali, Inc. is based in...

At a glance

Kali reported revenue of $94.55 million for fiscal year 2012, up 6.4% from fiscal year 2011, and net income of $17.52 million. In Q1 2013 (the quarter ended March 31, 2013) revenue was $26.61 million, up 75.5% from a year before.

Figures from company filings; latest fiscal year ended December 31, 2012.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.